Dectin-1 contributes to myocardial ischemia/reperfusion injury via immune cell regulation, presenting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Dectin-1 targeting in ischemia/reperfusion injury; human validation required before clinical consideration.
Our results reveal a crucial role of Dectin-1 in the process of mouse myocardial IR injury and provide a new, clinically significant therapeutic target.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: